Niki BioSolutions Biomarker Program Featured in Rett Research Series
The company’s blood-based microRNA biomarker panel is designed to support monitoring disease progression and treatment response in Rett syndrome.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The company’s blood-based microRNA biomarker panel is designed to support monitoring disease progression and treatment response in Rett syndrome.
Niki BioSolutions’ Rett Syndrome Biomarker Program was featured in the International Rett Syndrome Foundation’s “Rett Research Tool Belt” series.